Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Resignation of Senior Management Personnel'.
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Jitendra Mishra, Senior Vice President – IT, has resigned from Akums Drugs and Pharmaceuticals with effect from July 5, 2025. The company has accepted his resignation and no other material reasons were disclosed beyond those mentioned in his resignation letter. In his letter, Mr. Mishra cited a smooth transition and expressed gratitude for his experience, suggesting an amicable exit. This is a mid-level senior management departure in the IT function, not involving any C-suite or board-level executive.
Routine senior management change with no direct impact on operations, strategy, or shareholder value. Investors should monitor if this is part of broader IT leadership restructuring, but a single Sr. VP-IT exit is unlikely to move the stock.